Yatharth Hospitals
Yatharth Hospitals is an Indian for-profit private hospital chain serving North India through multispecialty and super-specialty hospitals.
Last updated August 26, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Yatharth Hospitals is the consumer-facing hospital brand of Yatharth Hospital & Trauma Care Services Ltd, an Indian for-profit private healthcare company operating in North India. The group was founded in 2008 by Dr. Ajay Kumar Tyagi and Dr. Kapil Kumar and developed from a single hospital operation into a regional network serving patients in Uttar Pradesh, Haryana, Madhya Pradesh, and New Delhi. Its facilities provide multispecialty and super-specialty care, trauma services, diagnostic support, emergency treatment, and medical education through Diplomate of National Board programs. The group's early expansion included a second hospital in Noida in 2013. In 2019, it opened a third facility in Noida Extension, strengthening its presence in the rapidly developing National Capital Region. The network subsequently expanded through a combination of new facilities and acquisitions. In 2024, Yatharth acquired the 175-bed Asian Fidelis Hospital in Faridabad for a reported consideration of ₹116 crore, expanded the facility to approximately 200 beds, and formally launched it under the group in May of that year. The company also announced plans to acquire the Delhi super-specialty hospital formerly known as MD City Hospital for approximately ₹160 crore and disclosed a strategic collaboration concerning the acquisition of a 60% stake in a 400-bed hospital in Faridabad, Haryana. In September 2025, the group announced the acquisition of Shantived Hospital in Agra. The company has been described as operating a network of seven or eight hospitals, depending on the point in the expansion cycle and the treatment of newly acquired facilities, with total capacity exceeding 2,500 beds. All of its hospitals are reported to hold accreditation from India's National Accreditation Board for Hospitals & Healthcare Providers. Its Greater Noida West facility is described as the first and only hospital in Uttar Pradesh to receive accreditation from Joint Commission International, an international healthcare quality and patient-safety accreditation body. Yatharth also has an education role. Its super-specialty hospitals in Noida Extension and Greater Noida offer DNB training in fields including general medicine, orthopaedics, general surgery, radiodiagnosis, paediatrics, emergency medicine, obstetrics and gynaecology, and anesthesiology. This gives the group a workforce-development and clinical-training function in addition to its hospital operations. Yatharth Hospital & Trauma Care Services Ltd became a publicly listed company in August 2023. In December 2024, it raised ₹625 crore through a qualified institutional placement, providing capital during a period of network expansion. The company has also faced scrutiny. In 2017, the family of a three-year-old child filed a police complaint alleging medical negligence involving doctors associated with Yatharth Super Speciality Hospital in Greater Noida and Jaypee Hospital. In a separate matter, India's National Organ & Tissue Transplant Organization sought a report from the Uttar Pradesh government after an alleged illegal organ-transplant racket linked to Indraprastha Apollo Hospital was reported to have connections with Yatharth Hospital in Noida. In 2023, Income Tax authorities conducted searches at locations in Delhi-NCR and Uttar Pradesh connected with the hospital, its promoters, and directors. These reports concern allegations, investigations, or official inquiries and do not by themselves establish wrongdoing by the company.
History
Yatharth Hospitals began operations in 2008 under the leadership of Dr. Ajay Kumar Tyagi and Dr. Kapil Kumar. The company was established as a private healthcare provider focused on hospital-based treatment in North India. Its growth model combined the development of new hospitals with expansion into increasingly specialized clinical services. The group opened its second hospital in Noida in 2013. A third hospital followed in Noida Extension in 2019, extending the network within the National Capital Region and positioning the brand in a growing suburban healthcare market. Over time, the organization developed a portfolio covering multispecialty medicine, super-specialty services, trauma care, emergency treatment, diagnostics, and inpatient care. Yatharth's facilities have been reported as accredited by the National Accreditation Board for Hospitals & Healthcare Providers. Its Greater Noida West hospital has also been described as the first and only hospital in Uttar Pradesh to receive Joint Commission International accreditation. The group has complemented its clinical operations with DNB teaching programs in Noida Extension and Greater Noida, covering disciplines such as general medicine, orthopaedics, surgery, radiodiagnosis, paediatrics, emergency medicine, obstetrics and gynaecology, and anesthesiology. The company entered a new phase of institutional growth after Yatharth Hospital & Trauma Care Services Ltd listed on Indian stock exchanges in August 2023. During 2023, the group also became the subject of official scrutiny when Income Tax authorities searched several premises associated with the hospital, its promoters, and directors in Delhi-NCR and Uttar Pradesh. Separately, NOTTO sought a report from the Uttar Pradesh government concerning alleged links between Yatharth Hospital in Noida and an illegal organ-transplant racket reported at Indraprastha Apollo Hospital. These matters were reported as investigations or allegations. Expansion accelerated in 2024. Yatharth acquired Asian Fidelis Hospital in Faridabad, a facility described as having 175 beds, for ₹116 crore. The group expanded the hospital to approximately 200 beds and formally launched it in May. It also announced the proposed acquisition of a Delhi super-specialty hospital previously known as MD City Hospital for approximately ₹160 crore, as well as a strategic collaboration relating to the acquisition of a 60% interest in a 400-bed hospital in Faridabad. In December 2024, the listed company raised ₹625 crore through a qualified institutional placement. The group continued its acquisition-led expansion in September 2025 with the announced acquisition of Shantived Hospital in Agra. Public descriptions of the network vary between seven and eight hospitals, reflecting the timing of announcements and the status of acquired facilities, but the group has been described as having more than 2,500 beds across four Indian states and the national capital territory. Its overall development has therefore followed a regional hospital-platform strategy: establish a presence in the National Capital Region, add clinical depth and teaching capacity, and expand the geographic footprint through hospital acquisitions.
- 2025
Shantived Hospital acquisition announced
[1]The group announced the acquisition of Shantived Hospital in Agra in September.
- 2024
Asian Fidelis Hospital acquisition
[1]Yatharth acquired the Faridabad-based Asian Fidelis Hospital and expanded its stated capacity to approximately 200 beds.
- 2024
Qualified institutional placement
[1]The company raised ₹625 crore through a qualified institutional placement in December.
- 2023
Public listing
[1]Yatharth Hospital & Trauma Care Services Ltd was listed on Indian stock exchanges in August.
- 2019
Third hospital opens in Noida Extension
[1]Yatharth opened a third hospital in Noida Extension.
- 2013
Second Noida hospital established
[1]The group established a 250-bed second hospital in Noida.
- 2008
Operations begin
[1]Yatharth Hospitals commenced operations under co-founders Dr. Ajay Kumar Tyagi and Dr. Kapil Kumar.
Products and positioning
A regional private hospital network combining multispecialty and super-specialty treatment, trauma care, accredited clinical facilities, and postgraduate medical education across North India.
Hospital care · 2008
Multispecialty hospital services
Yatharth's core offering is hospital-based multispecialty care. Its facilities bring together multiple medical and surgical departments, inpatient beds, outpatient consultations, diagnostics, emergency support, and related clinical services under one hospital network. The model is intended to serve both routine and complex cases across the group's North Indian operating markets.
Specialized medical services
Super-specialty care
The group's super-specialty hospitals provide advanced treatment programs beyond general multispecialty care. Public descriptions identify services associated with major medical and surgical disciplines, supported by specialist clinicians, diagnostic infrastructure, intensive care, and hospital-based treatment pathways. The precise service mix varies by facility.
Emergency medicine · 2008
Trauma and emergency care
Trauma and emergency treatment are part of the group's hospital proposition, reflected in the legal company name and its positioning as a hospital network serving urgent as well as scheduled medical needs. These services are delivered through hospital emergency departments and supporting specialties, although detailed operating metrics are not specified in the available material.
Medical education
DNB medical education
Yatharth Super Speciality Hospitals in Noida Extension and Greater Noida offer Diplomate of National Board training programs. Reported disciplines include general medicine, orthopaedics, general surgery, radio diagnosis, paediatrics, emergency medicine, obstetrics and gynaecology, and anesthesiology. The programs connect postgraduate clinical education with the group's hospital operations.
Controversies
2023
Tax searches involving company-linked premises
Income Tax authorities conducted searches at 15 locations in Delhi-NCR and Uttar Pradesh linked to Yatharth Hospital, its promoters, and directors. The reference material does not provide a final finding.
2017
Medical-negligence complaint involving a child
The family of a three-year-old child filed an FIR against five doctors associated with Yatharth Super Speciality Hospital in Greater Noida and Jaypee Hospital, alleging medical negligence. The available reference does not establish the final legal outcome.
Reported links to alleged illegal organ-transplant racket
NOTTO sought a report from the Uttar Pradesh government after an alleged illegal organ-transplant racket at Indraprastha Apollo Hospital was reported to have links with Yatharth Hospital in Noida. The available material describes an official request for information rather than a final adjudication.
Brand decisions
2025
Announce Shantived Hospital acquisitionM&ABackground
Yatharth sought to extend its North Indian network into Agra.
Action taken
The group announced the acquisition of Shantived Hospital in Agra in September 2025.
Aftermath
The available reference does not provide the transaction value or confirm the post-acquisition operating structure.
2024
Acquire and expand Asian Fidelis HospitalM&ABackground
Yatharth sought to expand its Faridabad presence and regional bed capacity through the purchase of an existing 175-bed multispecialty hospital.
Action taken
The group acquired Asian Fidelis Hospital for ₹116 crore, expanded the facility to approximately 200 beds, and launched it in May 2024.
Aftermath
The transaction added a Faridabad facility to the group's hospital network and increased its stated capacity.
Acquisition consideration. ₹116 crore (2024)
2024
Announce proposed Delhi hospital acquisitionM&ABackground
The company pursued additional super-specialty capacity in Delhi through a proposed acquisition.
Action taken
Yatharth announced the proposed acquisition of a Delhi super-specialty hospital previously known as MD City Hospital for approximately ₹160 crore.
Aftermath
Completion and subsequent operating status are not specified in the available reference.
Announced acquisition cost. Approximately ₹160 crore (2024)
2024
Pursue strategic stake in Faridabad hospitalM&ABackground
Yatharth continued expanding its regional hospital platform through a strategic collaboration.
Action taken
The company announced a strategic collaboration concerning the acquisition of a 60% stake in a 400-bed hospital in Faridabad, Haryana.
Aftermath
The available reference does not confirm completion of the transaction.
2024
Raise capital through qualified institutional placementOtherBackground
Following its 2023 public listing, the company raised institutional capital during a period of hospital-network expansion.
Action taken
Yatharth Hospital & Trauma Care Services raised ₹625 crore through a qualified institutional placement in December 2024.
Aftermath
The proceeds strengthened the company's capital base, although the available reference does not specify their precise allocation.
Capital raised. ₹625 crore (December 2024)
Recent events
- 2025
Yatharth announces acquisition of Shantived Hospital in Agra[1]
M&A
The group announced the acquisition of Shantived Hospital in Agra in September 2025.
- 2024
Yatharth Hospital raises ₹625 crore through qualified institutional placement[1]
Other
Yatharth Hospital & Trauma Care Services raised ₹625 crore through a qualified institutional placement in December 2024.
- 2024
Yatharth acquires and expands Asian Fidelis Hospital[1]
M&A · Other
The group acquired the Faridabad-based Asian Fidelis Hospital, expanded its capacity from 175 to approximately 200 beds, and launched the facility in May.
- 2024
Yatharth announces Delhi and Faridabad hospital expansion plans[1]
M&A
The company announced a proposed acquisition of the Delhi hospital formerly known as MD City Hospital and a strategic collaboration concerning a 60% stake in a 400-bed Faridabad hospital.
- 2023
Yatharth Hospital & Trauma Care Services listed on Indian stock exchanges[1]
Other
The company's shares began trading on Indian stock exchanges in August 2023.
Sources1 sources
Cite this profile: Cite the canonical profile. /brand-wiki/yatharth-hospitals · Editorial policy · How profiles are compiled